Resmed Inc
NYSE:RMD

Watchlist Manager
Resmed Inc Logo
Resmed Inc
NYSE:RMD
Watchlist
Price: 232.58 USD 0.61%
Market Cap: 34.1B USD
Have any thoughts about
Resmed Inc?
Write Note

Gross Margin
Resmed Inc

57.7%
Current
56%
Average
47.1%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
57.7%
=
Gross Profit
2.8B
/
Revenue
4.8B

Gross Margin Across Competitors

Country US
Market Cap 34.1B USD
Gross Margin
58%
Country US
Market Cap 199B USD
Gross Margin
56%
Country US
Market Cap 191.3B USD
Gross Margin
67%
Country US
Market Cap 141.3B USD
Gross Margin
64%
Country US
Market Cap 134.2B USD
Gross Margin
69%
Country IE
Market Cap 104.6B USD
Gross Margin
65%
Country US
Market Cap 65.6B USD
Gross Margin
45%
Country DE
Market Cap 58.1B EUR
Gross Margin
38%
Country US
Market Cap 44.5B USD
Gross Margin
79%
Country CN
Market Cap 311.1B CNY
Gross Margin
64%
Country US
Market Cap 36.3B USD
Gross Margin
41%
No Stocks Found

Resmed Inc
Glance View

Market Cap
34.1B USD
Industry
Health Care
Economic Moat
Narrow

ResMed Inc. has built its legacy on a profound, technological commitment to improving the lives of millions worldwide who suffer from sleep-related breathing disorders. Emerging as a beacon in the field of medical device innovation, the company is renowned for its focus on designing and manufacturing equipment to treat sleep apnea, a condition where breathing repeatedly stops and starts during sleep. Their product line, which includes continuous positive airway pressure (CPAP) devices, ventilators, and masks, caters to hospitals, home healthcare settings, and individuals. By addressing this critical health issue, ResMed doesn't just deliver therapeutic equipment; it offers a lifeline to those battling sleep health challenges, ensuring that restful nights translate into healthier days. The company's revenue model pivots around an integrated approach combining hardware sales, software solutions, and cloud-connected offerings. Through its software, ResMed analyzes vast pools of patient data, enabling healthcare providers to tailor and improve therapeutic protocols, thus driving the efficacy of treatment plans. The increasing turn towards digital health technologies has also opened new avenues, with the company's cloud platforms and analytics delivering value-added insights to care providers. This convergence of medical equipment and digital technology provides ResMed not just a steady growth trajectory, but also positions it at the forefront of a healthcare evolution, turning data-driven intelligence into actionable health solutions.

RMD Intrinsic Value
197.74 USD
Overvaluation 15%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
57.7%
=
Gross Profit
2.8B
/
Revenue
4.8B
What is the Gross Margin of Resmed Inc?

Based on Resmed Inc's most recent financial statements, the company has Gross Margin of 57.7%.